Brief: Interpace Announces Acceptance Of Seminal Clinical Validation Study For Thyroid Assays

Interpace Biosciences

21/07/2020 11:23

Interpace Biosciences Inc  IDXG.O :
    * INTERPACE ANNOUNCES ACCEPTANCE OF SEMINAL CLINICAL
VALIDATION
STUDY FOR THYROID ASSAYS

Source text for Eikon:  ID:nGNX8Z7kdf 
Further company coverage:  IDXG.O